All World Health Organization articles
-
NewsInteractions between flu subtypes predict epidemic severity more than virus evolution
An analysis of influenza virus evolution over 22 years of flu seasons reveals the major drivers of disease transmission and epidemic severity.
-
NewsGut bacteria of malnourished children benefit from key elements in therapeutic food
Researchers investigating a new therapeutic food aimed at repairing malnourished children’s underdeveloped gut microbiomes has identified key, naturally occurring biochemical components and the important bacterial strains that process these components.
-
NewsAI tool can help forecast viral outbreaks
A new AI tool called EVEscape uses evolutionary and biological information to predict how a virus could change to escape the immune syste, and successfully predicted the most concerning new variants that occurred during the COVID-19 pandemic.
-
NewsNew recommendation on meningitis vaccines for infants in sub-Saharan Africa
An IDCRC study assessing the meningococcal pentavalent (five in one) vaccine for infants in Africa shows vaccine provides protection against meningococcal meningitis.
-
NewsMore than 1 million lives saved across Europe by COVID-19 vaccines since the end of 2020
COVID-19 vaccination directly saved at least 1,004,927 lives across Europe between December 2020 and March 2023, according to new research being presented at ECCMID in Copenhagen, Denmark.
-
NewsEurope set to miss 2030 SDG target for ending TB as global threat
A new paper examining progress towards the Sustainable Development Goals target for tuberculosis and associated targets warns that as it stands, the EU/EEA will not reach the set targets by 2030.
-
NewsDose of antibiotic during labour can cut sepsis risk in developing countries
New findings suggest that a single dose of azithromycin given to women planning a vaginal delivery significantly reduces the risk of maternal death or sepsis.
-
OpinionManufacturing certainty on the origin of Covid-19 is damaging to science
Alina Chan reveals why it’s dangerous to insist that the lab leak theory is dead in the water.
-
NewsBiovac signs deal with IVI to deliver oral cholera vaccine for African and global markets
South African based Bio-pharmaceutical company Biovac has concluded a ground-breaking licensing and technology transfer agreement with the International Vaccine Institute (IVI), a non-profit international organisation headquartered in South Korea, for the manufacture of an oral cholera vaccine (OCV).
